Select Medical Holdings Co. (NYSE:SEM) Shares Acquired by Quadrature Capital Ltd

Quadrature Capital Ltd raised its stake in shares of Select Medical Holdings Co. (NYSE:SEM) by 54.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 39,490 shares of the health services provider’s stock after acquiring an additional 13,844 shares during the period. Quadrature Capital Ltd’s holdings in Select Medical were worth $928,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of Select Medical during the fourth quarter worth approximately $34,320,000. Vanguard Group Inc. raised its position in Select Medical by 2.9% during the 4th quarter. Vanguard Group Inc. now owns 12,347,798 shares of the health services provider’s stock worth $290,173,000 after buying an additional 342,496 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Select Medical by 15.7% in the 4th quarter. Victory Capital Management Inc. now owns 1,739,361 shares of the health services provider’s stock worth $40,875,000 after acquiring an additional 235,964 shares during the period. First Eagle Investment Management LLC increased its stake in shares of Select Medical by 151.2% during the fourth quarter. First Eagle Investment Management LLC now owns 240,047 shares of the health services provider’s stock worth $5,641,000 after acquiring an additional 144,500 shares during the period. Finally, Trexquant Investment LP raised its holdings in Select Medical by 257.8% during the third quarter. Trexquant Investment LP now owns 165,742 shares of the health services provider’s stock worth $4,188,000 after purchasing an additional 119,416 shares in the last quarter. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Price Performance

SEM stock opened at $33.72 on Friday. The firm has a 50 day moving average of $31.81 and a 200-day moving average of $28.45. The company has a market cap of $4.38 billion, a price-to-earnings ratio of 16.06, a PEG ratio of 1.62 and a beta of 1.44. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 2.30. Select Medical Holdings Co. has a 12-month low of $21.28 and a 12-month high of $35.08.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, May 2nd. The health services provider reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.55 by $0.22. Select Medical had a return on equity of 18.11% and a net margin of 3.97%. The firm had revenue of $1.79 billion during the quarter, compared to analysts’ expectations of $1.70 billion. As a group, equities analysts expect that Select Medical Holdings Co. will post 2.1 EPS for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 30th. Shareholders of record on Thursday, May 16th were given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend was Wednesday, May 15th. Select Medical’s payout ratio is currently 23.81%.

Insider Activity

In related news, Chairman Robert A. Ortenzio sold 50,000 shares of Select Medical stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the completion of the transaction, the chairman now directly owns 6,689,668 shares in the company, valued at approximately $200,021,073.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 19.14% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a report on Friday, March 22nd. Royal Bank of Canada lifted their price target on Select Medical from $36.00 to $40.00 and gave the company an “outperform” rating in a research note on Monday, May 6th. Finally, Benchmark reiterated a “buy” rating and issued a $39.00 price objective on shares of Select Medical in a research report on Friday, May 3rd. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Select Medical has a consensus rating of “Moderate Buy” and an average target price of $34.25.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.